Lv1
30 积分 2023-11-19 加入
Nomogram for predicting recurrence and metastasis of stage IA lung adenocarcinoma treated by videoassisted thoracoscopic lobectomy
3天前
已完结
Impacts of additional cycles of neoadjuvant immunotherapy on surgery in non‐small‐cell lung cancer
11天前
已完结
Real-World Analysis of Post-Progression Treatment Patterns and Outcomes for EGFR Mutation-Positive Patients Treated with First-Line Osimertinib
1个月前
已完结
LBA93 EXTENTORCH: A randomized, phase III trial of toripalimab versus placebo, in combination with chemotherapy as a first-line therapy for patients with extensive stage small cell lung cancer (ES-SCLC)
1个月前
已完结
A review of recent advances in the novel therapeutic targets and immunotherapy for lung cancer
2个月前
已完结
A Novel Machine Learning Model for Efficacy Prediction of Immunotherapy-Chemotherapy in NSCLC Based on CT Radiomics
3个月前
已完结
Comparison of Real-world Efficacy and Safety of Atezolizumab and Durvalumab in Combination With Chemotherapy for First-line Treatment of Extensive-stage Small-cell Lung Cancer
4个月前
已完结
Chemoimmunotherapy in patients with extensive‐stage small cell lung cancer and a poor performance status
4个月前
已完结
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
4个月前
已完结
519P Final results and subgroup analysis of ORIENTAL: A phase IIIB study of durvalumab plus platinum-etoposide in first-line treatment of Chinese patients with extensive-stage small-cell lung cancer (ES-SCLC)
4个月前
已关闭
皖公网安备34019202002308
